Deep brain stimulation in Gilles de la Tourette syndrome: killing several birds with one stone? [version 1; referees: 2 approved]

In patients with severe, treatment-refractory Gilles de la Tourette syndrome (GTS), deep brain stimulation (DBS) of various targets has been increasingly explored over the past 15 years. The multiplicity of surgical targets is intriguing and may be partly due to the complexity of GTS, specifically t...

Full description

Bibliographic Details
Main Author: Andreas Hartmann
Format: Article
Language:English
Published: F1000 Research Ltd 2016-09-01
Series:F1000Research
Subjects:
Online Access:http://f1000research.com/articles/5-2255/v1
id doaj-719b046dd2214ff0bad6d95b7986d0ce
record_format Article
spelling doaj-719b046dd2214ff0bad6d95b7986d0ce2020-11-25T03:06:25ZengF1000 Research LtdF1000Research2046-14022016-09-01510.12688/f1000research.9521.110256Deep brain stimulation in Gilles de la Tourette syndrome: killing several birds with one stone? [version 1; referees: 2 approved]Andreas Hartmann0French Reference Centre for Gilles de la Tourette Syndrome, Groupe Hospitalier Pitié-Salpêtrière, Paris, FranceIn patients with severe, treatment-refractory Gilles de la Tourette syndrome (GTS), deep brain stimulation (DBS) of various targets has been increasingly explored over the past 15 years. The multiplicity of surgical targets is intriguing and may be partly due to the complexity of GTS, specifically the various and frequent associated psychiatric comorbidities in this disorder. Thus, the target choice may not only be aimed at reducing tics but also comorbidities. While this approach is laudable, it also carries the risk to increase confounding factors in DBS trials and patient evaluation. Moreover, I question whether DBS should really be expected to alleviate multiple symptoms at a time. Rather, I argue that tic reduction should remain our primary objective in severe GTS patients and that this intervention may subsequently allow an improved psychotherapeutic and/or pharmacological treatment of comorbidities. Thus, I consider DBS in GTS not as a single solution for all our patients’ ailments but as a stepping stone to improved holistic care made possible by tic reduction.http://f1000research.com/articles/5-2255/v1Movement Disorders
collection DOAJ
language English
format Article
sources DOAJ
author Andreas Hartmann
spellingShingle Andreas Hartmann
Deep brain stimulation in Gilles de la Tourette syndrome: killing several birds with one stone? [version 1; referees: 2 approved]
F1000Research
Movement Disorders
author_facet Andreas Hartmann
author_sort Andreas Hartmann
title Deep brain stimulation in Gilles de la Tourette syndrome: killing several birds with one stone? [version 1; referees: 2 approved]
title_short Deep brain stimulation in Gilles de la Tourette syndrome: killing several birds with one stone? [version 1; referees: 2 approved]
title_full Deep brain stimulation in Gilles de la Tourette syndrome: killing several birds with one stone? [version 1; referees: 2 approved]
title_fullStr Deep brain stimulation in Gilles de la Tourette syndrome: killing several birds with one stone? [version 1; referees: 2 approved]
title_full_unstemmed Deep brain stimulation in Gilles de la Tourette syndrome: killing several birds with one stone? [version 1; referees: 2 approved]
title_sort deep brain stimulation in gilles de la tourette syndrome: killing several birds with one stone? [version 1; referees: 2 approved]
publisher F1000 Research Ltd
series F1000Research
issn 2046-1402
publishDate 2016-09-01
description In patients with severe, treatment-refractory Gilles de la Tourette syndrome (GTS), deep brain stimulation (DBS) of various targets has been increasingly explored over the past 15 years. The multiplicity of surgical targets is intriguing and may be partly due to the complexity of GTS, specifically the various and frequent associated psychiatric comorbidities in this disorder. Thus, the target choice may not only be aimed at reducing tics but also comorbidities. While this approach is laudable, it also carries the risk to increase confounding factors in DBS trials and patient evaluation. Moreover, I question whether DBS should really be expected to alleviate multiple symptoms at a time. Rather, I argue that tic reduction should remain our primary objective in severe GTS patients and that this intervention may subsequently allow an improved psychotherapeutic and/or pharmacological treatment of comorbidities. Thus, I consider DBS in GTS not as a single solution for all our patients’ ailments but as a stepping stone to improved holistic care made possible by tic reduction.
topic Movement Disorders
url http://f1000research.com/articles/5-2255/v1
work_keys_str_mv AT andreashartmann deepbrainstimulationingillesdelatourettesyndromekillingseveralbirdswithonestoneversion1referees2approved
_version_ 1724674245347246080